Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CVM Updates

CVM Updates Home
          Animal & Veterinary
          News & Events
          CVM Updates
          FDA Announces Draft Guidance on Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Drug ProductsCVM Updates FDA Announces Draft Guidance on Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Drug Products
  
  	
    Share
    Post
    Linkedin

    Email
    PrintJanuary 24, 2024

Today, the U.S. Food and Drug Administration is announcing the availability of a draft guidance for industry (GFI) #286 (VICH GL60) entitled, “Good Manufacturing Practice for Active Pharmaceutical Ingredients used in Veterinary Medicinal Products.” This draft guidance has been developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).

VICH is a trilateral program officially launched in April 1996. The program aims to harmonize technical requirements for the approval of veterinary medicinal products in the European Union, Japan, and the United States, and includes input from both regulatory and industry representatives. In support of wider international harmonization of regulatory requirements, VICH guidelines are also available for use by other countries.

This draft guideline has been developed based on a similar guideline (ICH Q7: Good Manufacturing Practices for Active Pharmaceutical Ingredients) intended to cover human drugs from the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). The objective of this draft guidance is to provide recommendations regarding good manufacturing practices (GMPs) for the manufacturing of active pharmaceutical ingredients (APIs) for use in veterinary medicinal products. It facilitates harmonization of a single set of international standards for GMP inspections of facilities that manufacture APIs and starting materials for use in such products. It also allows manufacturers and regulators a framework to ensure that APIs meet the quality and purity characteristics that they are intended to possess.

The FDA has participated in efforts to enhance international harmonization and is committed to seeking scientifically based harmonized technical procedures for pharmaceutical development. One of the goals of harmonization is to identify, and then reduce, differences in technical requirements for drug development among regulatory agencies in different countries. The FDA’s work with VICH aims to ensure regulatory certainty for veterinary products, including predictable and uniform requirements across the E.U., Japan and the U.S. The collective work also helps to reduce animal testing, facilitate trade, and ensure veterinary product safety and consumer confidence in the regulated products.

Although the public may submit comments on any FDA guidance document at any time, the agency is encouraging the public to submit comment(s) on the draft guidance within 60 days to ensure that the FDA considers your comment(s) before it begins work on the final version of the guidance document. To submit comments electronically, visit https://www.regulations.gov and type the following docket number into the search box: FDA-2023-D-4761.

The public may also submit comments by mail using the address below:

Dockets Management Staff 
HFA-305 
Food and Drug Administration 
5630 Fishers Lane, Room 1061 
Rockville, MD 20852.

**For more information:**

draft guidance for industry (GFI) #286 (VICH GL60), “Good Manufacturing Practice for Active Pharmaceutical Ingredients used in Veterinary Medicinal Products”
	Veterinary International Conference on Harmonization (VICH) Guidance Documents
	ICH Q7: Good Manufacturing Practices for Active Pharmaceutical Ingredients**Issued by FDA Center for Veterinary Medicine.
For questions, Contact CVM.**

                                                                                  Content current as of:
      01/24/2024CVM Updates
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop